z-logo
open-access-imgOpen Access
Risk Factors, Screening Results and Intravitreal Ranibizumab Treatment of Retinopathy of Prematurity
Author(s) -
Baran Cengiz Arcagök
Publication year - 2021
Publication title -
haydarpaşa numune hastanesi tıp dergisi
Language(s) - English
Resource type - Journals
ISSN - 1300-6363
DOI - 10.14744/hnhj.2021.85619
Subject(s) - retinopathy of prematurity , ranibizumab , medicine , ophthalmology , optometry , bevacizumab , pregnancy , gestational age , biology , chemotherapy , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here